Registry of restriction intentions until outcome
Registry of restriction intentions until outcome
Chromium trioxide, acids generated from chromium trioxide and their oligomers
EC / List no: - CAS no: -| CLP Annex VI Index number | |
| Further substance information | |
| Submitter(s) | ECHA |
| Details on the scope of restriction | Restricting the use of certain chromium (VI) substances. |
| Reason for restriction | The number of applications for authorisation for the use of certain Cr(VI) substances has far exceeded the predictions at the time of inclusion of the substances in REACH Annex XIV, and the approach envisaged for regulating Cr(VI) substances (authorisation) is no longer appropriate to control the risk to human health posed by these substances. The Commission is therefore requesting ECHA to prepare a restriction dossier in line with the requirements of Annex XV. |
| Remarks | The Dossier Submitter will take stock of the granted authorisations as well as processed and pending applications for authorisations for the chromium (VI) substances in scope of the restriction proposal. Stakeholders are requested to provide relevant information to the Dossier Submitter. If justified based on robust risk and socio-economic information the Dossier Submitter may propose derogations from the proposed restriction. If a derogation is not proposed by the Dossier Submitter then it will be incumbent on the relevant stakeholders to do so during any consultation process with a full risk and socio-economic justification accompanying it. Link to the Commission’s Q&A: https://ec.europa.eu/docsroom/documents/56174 Update 8 May 2024: Based on ECHA findings and by request from the Commission, the Intention has been amended to extend the scope and timeline to prepare the Annex XV dossier. The Commission amendment to the initial request can be found at the following link: https://echa.europa.eu/current-activities-on-restrictions In addition to entry 16 on chromium trioxide, and entry 17 on acids generated from chromium trioxide and their oligomers currently listed on REACH Annex XIV, the scope of the Annex XV dossier also covers REACH Annex XIV entries 18, 19, 20, 21, 22, 28, 29, 30, 31, and Cr(VI) substances not listed in Annex XIV but with the potential to lead to regrettable substitution, in particular barium chromate. |
| Status | Intention |
| Date of intention | 05-Oct-2023 |
| Expected date of submission | 11-Apr-2025 |
| Withdrawal date | |
| Reason for withdrawal | |
| Start of Call for Evidence consultation | 13-Dec-2023 |
| Deadline for comments on the Call for Evidence | 27-Feb-2024 |
| Start of second Call for Evidence consultation | |
| Deadline for comments on the second Call for Evidence | |
| Start of third Call for Evidence consultation | |
| Deadline for comments on the third Call for Evidence | |
| Restriction report (and annexes) | |
| Information note on restriction report | |
| Start of Annex XV report consultation | |
| 1st deadline for comments on Annex XV report | |
| Final deadline for comments on Annex XV report | |
| Comments on Annex XV report | |
| Opinion of RAC (and minority positions) and Forum Enforceability Advice (as of September 2023) | |
| Draft opinion of SEAC | |
| RAC & SEAC (draft) Background document (and annexes) | |
| Start of SEAC draft opinion consultation | |
| Deadline for comments on SEAC draft opinion | |
| Comments on SEAC draft opinion | |
| Compiled RAC and SEAC opinion (and minority positions) | |
| Final background document (and annexes) | |
| Adopted restriction/Commission communication | |
| Latest update | 08-May-2024 |
| First published | 11-Oct-2023 |